301 related articles for article (PubMed ID: 34246244)
1. Characterisation of the clinical phenotype in Phelan-McDermid syndrome.
Burdeus-Olavarrieta M; San José-Cáceres A; García-Alcón A; González-Peñas J; Hernández-Jusdado P; Parellada-Redondo M
J Neurodev Disord; 2021 Jul; 13(1):26. PubMed ID: 34246244
[TBL] [Abstract][Full Text] [Related]
2. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case.
Samogy-Costa CI; Varella-Branco E; Monfardini F; Ferraz H; Fock RA; Barbosa RHA; Pessoa ALS; Perez ABA; Lourenço N; Vibranovski M; Krepischi A; Rosenberg C; Passos-Bueno MR
J Neurodev Disord; 2019 Jul; 11(1):13. PubMed ID: 31319798
[TBL] [Abstract][Full Text] [Related]
3. A 29 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes.
Xu N; Lv H; Yang T; Du X; Sun Y; Xiao B; Fan Y; Luo X; Zhan Y; Wang L; Li F; Yu Y
Orphanet J Rare Dis; 2020 Nov; 15(1):335. PubMed ID: 33256793
[TBL] [Abstract][Full Text] [Related]
4. Gait Abnormalities in Children with Phelan-McDermid Syndrome.
Frank Y; Levy T; Lozano R; Friedman K; Underwood S; Kostic A; Walker H; Kolevzon A
J Child Neurol; 2023 Dec; 38(13-14):665-671. PubMed ID: 37849292
[No Abstract] [Full Text] [Related]
5. Prospective study of autism phenomenology and the behavioural phenotype of Phelan-McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder.
Richards C; Powis L; Moss J; Stinton C; Nelson L; Oliver C
J Neurodev Disord; 2017 Nov; 9(1):37. PubMed ID: 29126394
[TBL] [Abstract][Full Text] [Related]
6. Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations.
Oberman LM; Boccuto L; Cascio L; Sarasua S; Kaufmann WE
Orphanet J Rare Dis; 2015 Aug; 10():105. PubMed ID: 26306707
[TBL] [Abstract][Full Text] [Related]
7. 22q13 deletion syndrome: communication disorder or autism? Evidence from a specific clinical and neurophysiological phenotype.
Ponson L; Gomot M; Blanc R; Barthelemy C; Roux S; Munnich A; Romana S; Aguillon-Hernandez N; Malan V; Bonnet-Brilhault F
Transl Psychiatry; 2018 Aug; 8(1):146. PubMed ID: 30089781
[TBL] [Abstract][Full Text] [Related]
8. [Advance of research on Phelan-McDermid syndrome].
Li S; Xi K; Liu T; Zhang Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Sep; 38(9):917-920. PubMed ID: 34487544
[TBL] [Abstract][Full Text] [Related]
9. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
[TBL] [Abstract][Full Text] [Related]
10. Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome.
Schön M; Lapunzina P; Nevado J; Mattina T; Gunnarsson C; Hadzsiev K; Verpelli C; Bourgeron T; Jesse S; van Ravenswaaij-Arts CMA; ; Hennekam RC
Eur J Med Genet; 2023 Jul; 66(7):104754. PubMed ID: 37003575
[TBL] [Abstract][Full Text] [Related]
11. Consensus recommendations on communication, language and speech in Phelan-McDermid syndrome.
Burdeus-Olavarrieta M; Nevado J; van Weering-Scholten S; Parker S; ; Swillen A
Eur J Med Genet; 2023 May; 66(5):104745. PubMed ID: 36871884
[TBL] [Abstract][Full Text] [Related]
12. Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by
De Rubeis S; Siper PM; Durkin A; Weissman J; Muratet F; Halpern D; Trelles MDP; Frank Y; Lozano R; Wang AT; Holder JL; Betancur C; Buxbaum JD; Kolevzon A
Mol Autism; 2018; 9():31. PubMed ID: 29719671
[TBL] [Abstract][Full Text] [Related]
13. Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.
Costales JL; Kolevzon A
Neurotherapeutics; 2015 Jul; 12(3):620-30. PubMed ID: 25894671
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: Sensory Reactivity in Children with Phelan-McDermid Syndrome.
Mieses AM; Tavassoli T; Li E; Soorya L; Lurie S; Wang AT; Siper PM; Kolevzon A
J Autism Dev Disord; 2016 Jul; 46(7):2508-13. PubMed ID: 26914612
[TBL] [Abstract][Full Text] [Related]
15. The Neurological Manifestations of Phelan-McDermid Syndrome.
Frank Y
Pediatr Neurol; 2021 Sep; 122():59-64. PubMed ID: 34325981
[TBL] [Abstract][Full Text] [Related]
16. Parental perspectives on Phelan-McDermid syndrome: Results of a worldwide survey.
Landlust AM; Koza SA; Carbin M; Walinga M; Robert S; Cooke J; Vyshka K; ; van Balkom IDC; van Ravenswaaij-Arts C
Eur J Med Genet; 2023 Jul; 66(7):104771. PubMed ID: 37120079
[TBL] [Abstract][Full Text] [Related]
17. Psychiatric illness and regression in individuals with Phelan-McDermid syndrome.
Kohlenberg TM; Trelles MP; McLarney B; Betancur C; Thurm A; Kolevzon A
J Neurodev Disord; 2020 Feb; 12(1):7. PubMed ID: 32050889
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genomic evaluation of a Chinese patient with a novel deletion associated with Phelan-McDermid syndrome.
Lei D; Li S; Banerjee S; Zhang H; Li C; Hou S; Chen D; Yan H; Li H; Peng HH; Liu S; Zhang X; Peng Z; Wang J; Yang H; Huang H; Wu J
Oncotarget; 2016 Dec; 7(49):80327-80335. PubMed ID: 27741506
[TBL] [Abstract][Full Text] [Related]
19. Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.
Harony-Nicolas H; De Rubeis S; Kolevzon A; Buxbaum JD
J Child Neurol; 2015 Dec; 30(14):1861-70. PubMed ID: 26350728
[TBL] [Abstract][Full Text] [Related]
20. Psychometric Study of the Social Responsiveness Scale in Phelan-McDermid Syndrome.
Gergoudis K; Weinberg A; Templin J; Farmer C; Durkin A; Weissman J; Siper P; Foss-Feig J; Del Pilar Trelles M; Bernstein JA; Buxbaum JD; Berry-Kravis E; Powell CM; Sahin M; Soorya L; Thurm A; Kolevzon A;
Autism Res; 2020 Aug; 13(8):1383-1396. PubMed ID: 32406614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
